Article
Dolutegravir-based antiretroviral therapy for patients co-infected with tuberculosis and HIV: a multicenter, noncomparative, open-label, randomized trial
Fecha
2019Registro en:
DOOLEY, Kelly E. et al. Dolutegravir-based antiretroviral therapy for patients co-infected with tuberculosis and HIV: a multicenter, noncomparative, open-label, randomized trial. Clinical Infectious Diseases, p. 1-20, Mar. 2019.
1058-4838
10.1093/cid/ciz256
1537-6591
Autor
Dooley, Kelly E.
Kaplan, Richard
Mwelase, Noluthando
Grinsztejn, Beatriz
Ticona, Eduardo
Lacerda, Marcus
Sued, Omar
Belonosova, Elena
Ait-Khaled, Mounir
Angelis, Konstantinos
Brown, Dannae
Singh, Rajendra
Talarico, Christine L.
Tenorio, Allan R.
Keegan, Michael R.
Aboud, Michael